Q4 & FY22 Highlights

Dr Lal PathLabs May 23, 2022 National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E) Mumbai 400 051 BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001 Subject: Corporate Presentation Q4 & FY22 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), please find attached herewith Corporate Presentation of the Company for Q4 & FY22, which the Company proposes to share with analysts/ investors. We request you to please take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Rajat Kalra Company Secretary and Legal Head Encl. As above Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-18, Rohini, New Delhi - 110085, +91-11-30258600, Fax: +91-11-2788-2134 Corporate Office: Dr. Lal PathLabs Ltd., 12th Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122 001, Haryana +91-124-3016-500, Fax: +91-124-4234-468 E-mail: [email protected], Web: www.lalpathlabs.com, CIN No.: L74899DL1995PLC065388

View entire presentation